| Cardiovascular Risk Management |
1 |
1 |
| Lipids Management |
0 |
1 |
| Coronary Artery Disease (CAD) |
0 |
0.99 |
| Statins |
0 |
0.98 |
| Angina Pectoris |
0 |
0.49 |
| Acute Coronary Syndrome |
0 |
0.47 |
| Artery |
0 |
0.38 |
| Thromboembolism |
0 |
0.38 |
| Atrial Fibrillation |
0 |
0.33 |
| Cerebrovascular Accident |
0 |
0.33 |
| Unstable Angina |
0 |
0.28 |
| Fatty Acids |
0 |
0.19 |
| Heart |
0 |
0.19 |
| Ischemic Stroke |
0 |
0.19 |
| LDL Cholesterol |
0 |
0.16 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Myocardial Infarction (MI) |
0 |
0.1 |
| Patient Safety |
0 |
0.1 |
| Adverse Effects |
0 |
0.09 |
| California |
0 |
0.09 |
| Cardiovascular disease |
0 |
0.09 |
| Clinical Research |
0 |
0.09 |
| Infarction |
0 |
0.09 |
| Isolation |
0 |
0.09 |
| Lipoproteins |
0 |
0.09 |
| Minerals |
0 |
0.09 |
| Sudden Cardiac Death |
0 |
0.09 |
| Triglycerides |
0 |
0.09 |
| Weakness |
0 |
0.09 |